| 2014 | 2015 | 2016 | 2018 | 2019 (projected) | DaVita Current Assets | 3,636,170,000 | 4,503,280,000 | 3,980,228,000 | 3,582,205,200 | 544,526,000 | DaVita Total Assets | 17,617,432,000 | 18,514,875,000 | 18,741,257,000 | 16,867,131,300 | 1,775,693,000 |
Does DaVita have anything left for July?
 | By Rifka Kats | Macroaxis Story |
This article is aimed at all current or potential DaVita investors. I will look into why albeit cyclical DaVita disturbance, the long term basic indicators of the company are still strong. DaVita almost mirrors market. The returns on investing in DaVita and the market returns of the last few months appear uncorrelated. The appearance of strong basic indicators of the company suggests short term price swing for investors of the company. Macroaxis considers DaVita to be not too volatile. DaVita secures Sharpe Ratio (or Efficiency) of -0.1007 which denotes the organization had -0.1007% of return per unit of volatility over the last 1 month. Macroaxis way in which we are predicting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. DaVita exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm DaVita Mean Deviation of 1.87 to check risk estimate we provide.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Vlad Skutelnik
This firm average rating is Hold from 9 analysts. As of 15 of June DaVita shows Mean Deviation of 1.87. DaVita technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for DaVita which can be compared to its rivals. Please confirm DaVita Maximum Drawdown as well as the relationship between Downside Variance and Skewness to decide if DaVita is priced more or less accurately providing market reflects its regular price of 48.08 per share. Given that DaVita has Jensen Alpha of 0.0, we urge you verify DaVita prevailing market performance to make sure the company can sustain itself next year.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DaVita HealthCare. Your research has to be compared to or analyzed against DaVita HealthCare's peers to derive any actionable benefits. When done correctly, DaVita HealthCare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DaVita HealthCare.
Using predictive technical analysis, we can analyze different prices and returns patterns and diagnose historical swings to determine the real value of DaVita HealthCare Partners. In general, sophisticated investors focus on analyzing DaVita HealthCare stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build DaVita HealthCare's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of DaVita HealthCare's intrinsic value. In addition to deriving basic predictive indicators for DaVita HealthCare, many experienced traders also check how macroeconomic factors affect DaVita HealthCare price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DaVita HealthCare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
How does DaVita Stands against Peers?
Analyzing DaVita HealthCare competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to DaVita HealthCare across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out DaVita HealthCare Competition DetailsDaVita HealthCare Gross Profit
DaVita HealthCare Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing DaVita HealthCare previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show DaVita HealthCare Gross Profit growth over the last 10 years. Please check DaVita HealthCare's gross profit and other fundamental indicators for more details.
Another angle On DaVita HealthCare
The recent DaVita price drops could raise concerns from investors as the firm closed today at a share price of 47.215 on 1427225.000 in volume. The company directors and management were unable to exploit market volatilities in May. However, diversifying your overall positions with DaVita can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 2.7028. The current volatility is consistent with the ongoing market swings in May 2019 as well as with DaVita unsystematic, company specific events. DaVita makes 23.29x book value per share. DaVita is trading at 48.08. This is 1.64 percent decrease. Started trading at 48.08. DaVita Cash and Equivalents USD is increasing over the last 5 years. The current value of DaVita Cash and Equivalents USD is 661,447,289. DaVita Price to Book Value is decreasing over the last 5 years. The previous year value of DaVita Price to Book Value was 2.11. Furthermore, DaVita Total Debt USD is increasing over the last 5 years. The previous year value of DaVita Total Debt USD was 6,318,403,053.
On the whole, I belive DaVita is currently undervalued. It Almost mirrors market and projects very small odds of distress in the next two years. Our up-to-date buy/sell recommendation on the company is Cautious Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of DaVita HealthCare Partners. Please refer to our Terms of Use for any information regarding our disclosure principles.